Company Filing History:
2 out of 151 
1 out of 2,488 
1 out of 1,157 Years Active: 2014-2019
Title: Oliver Zoechling: Innovator in Therapeutic Protein Conjugation
Introduction
Oliver Zoechling is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of therapeutic proteins through his innovative patents. With a total of two patents to his name, Zoechling's work focuses on enhancing the conjugation of water-soluble polymers to therapeutic proteins.
Latest Patents
Zoechling's latest patents include advancements in nucleophilic catalysts for oxime linkage. His invention relates to materials and methods for conjugating a water-soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein. This process involves contacting the oxidized carbohydrate moiety with an activated water-soluble polymer under conditions that facilitate conjugation. Specifically, the water-soluble polymer contains an active aminooxy group, allowing for the formation of an oxime or hydrazone linkage between the oxidized carbohydrate moiety and the active aminooxy group. The conjugation is carried out in the presence of a nucleophilic catalyst, showcasing Zoechling's innovative approach to improving therapeutic protein functionality.
Career Highlights
Throughout his career, Oliver Zoechling has worked with prominent companies in the biotechnology sector, including Baxalta GmbH and Baxter International Inc. His experience in these organizations has contributed to his expertise in the field of therapeutic proteins and polymer conjugation.
Collaborations
Zoechling has collaborated with notable colleagues such as Juergen Siekmann and Stefan Haider. These collaborations have likely enriched his research and development efforts, leading to impactful innovations in his field.
Conclusion
Oliver Zoechling stands out as an inventor dedicated to advancing therapeutic protein technologies. His patents reflect a commitment to improving the efficacy of therapeutic proteins through innovative conjugation methods. His contributions are significant in the realm of biotechnology and therapeutic development.